Josephine M Forbes Selected Research

Lipids

1/2022	Hypoxic human proximal tubular epithelial cells undergo ferroptosis and elicit an NLRP3 inflammasome response in CD1c+ dendritic cells.
9/2010	The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
1/2009	A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches?
8/2008	Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs.
4/2008	Therapeutic interruption of advanced glycation in diabetic nephropathy: do all roads lead to Rome?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josephine M Forbes Research Topics

Disease

38	Diabetic Nephropathies (Diabetic Nephropathy) 12/2023 - 11/2002
20	Albuminuria 01/2020 - 05/2002
16	Inflammation (Inflammations) 12/2023 - 04/2008
15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 08/2005
11	Fibrosis (Cirrhosis) 01/2022 - 09/2003
10	Type 2 Diabetes Mellitus (MODY) 09/2020 - 04/2009
8	Insulin Resistance 01/2022 - 08/2005
7	Obesity 06/2022 - 08/2005
7	Hyperglycemia 11/2020 - 08/2005
7	Diabetes Complications 09/2020 - 03/2003
6	Kidney Diseases (Kidney Disease) 06/2022 - 01/2013
6	Atherosclerosis 11/2020 - 07/2004
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 08/2013
5	Chronic Disease (Chronic Diseases) 01/2020 - 07/2011
4	Chronic Renal Insufficiency 12/2023 - 01/2016
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 02/2012
4	Critical Illness (Critically Ill) 01/2022 - 04/2018
4	Hypertension (High Blood Pressure) 11/2021 - 05/2002
4	Body Weight (Weight, Body) 01/2018 - 07/2013
4	Proteinuria 02/2016 - 05/2002
3	Overweight 11/2021 - 06/2016
3	Prediabetic State (Prediabetes) 06/2021 - 04/2015
3	Non-alcoholic Fatty Liver Disease 10/2019 - 04/2014
3	Hypertrophy 08/2008 - 09/2003
2	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 04/2018
2	Necrosis 01/2022 - 01/2017
2	Dyslipidemias (Dyslipidemia) 11/2021 - 09/2010
2	Sclerosis 07/2021 - 09/2010
2	Experimental Diabetes Mellitus 01/2021 - 03/2003
2	Neoplasms (Cancer) 04/2020 - 05/2013
2	Hypoxia (Hypoxemia) 01/2020 - 01/2018
2	Disease Progression 10/2019 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2016 - 04/2014
2	Fatty Liver 09/2016 - 04/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2013 - 04/2009
2	Vascular Diseases (Vascular Disease) 05/2013 - 09/2009
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Glucose Intolerance 11/2021

Drug/Important Bio-Agent (IBA)

40	Advanced Glycation End ProductsIBA 11/2022 - 11/2002
15	Receptor for Advanced Glycation End ProductsIBA 12/2023 - 08/2005
15	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 08/2005
11	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2002
10	Insulin (Novolin)FDA Link 01/2022 - 09/2005
10	alagebriumIBA 06/2021 - 04/2003
7	Dietary Advanced Glycation End ProductsIBA 06/2022 - 03/2010
6	AlbuminsIBA 01/2021 - 09/2003
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 02/2008
6	Superoxides (Superoxide)IBA 04/2014 - 08/2008
5	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2022 - 09/2009
5	LipidsIBA 01/2022 - 04/2008
5	CollagenIBA 07/2021 - 08/2004
5	CreatinineIBA 01/2021 - 09/2009
5	Adenosine Triphosphate (ATP)IBA 01/2020 - 03/2010
5	AntioxidantsIBA 08/2013 - 03/2007
4	ChloridesIBA 06/2021 - 08/2008
4	Apolipoproteins E (ApoE)IBA 09/2010 - 07/2004
3	LigandsIBA 01/2023 - 08/2010
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2012
3	ApolipoproteinsIBA 01/2021 - 07/2004
3	CholesterolIBA 11/2020 - 04/2008
3	GlycogenIBA 04/2020 - 01/2015
3	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2019 - 01/2016
3	CarbohydratesIBA 01/2019 - 04/2018
3	Biomarkers (Surrogate Marker)IBA 02/2016 - 01/2011
3	Ramipril (Altace)FDA LinkGeneric 01/2014 - 06/2003
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2010 - 02/2008
3	AngiotensinsIBA 01/2010 - 03/2003
3	CytokinesIBA 04/2008 - 12/2002
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023 - 09/2020
2	C-Reactive ProteinIBA 01/2022 - 01/2017
2	EnzymesIBA 01/2022 - 03/2003
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2022 - 09/2016
2	Syntex adjuvant formulationIBA 01/2021 - 01/2015
2	Complement C5a (Complement 5a)IBA 01/2021 - 01/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2020 - 09/2010
2	Hormones (Hormone)IBA 09/2020 - 01/2018
2	Liver GlycogenIBA 01/2017 - 01/2015
2	Triglycerides (Triacylglycerol)IBA 01/2017 - 04/2014
2	Glutathione PeroxidaseIBA 02/2016 - 06/2003
2	empagliflozinIBA 01/2016 - 01/2016
2	Streptozocin (Streptozotocin)FDA Link 09/2010 - 07/2004
2	NF-kappa B (NF-kB)IBA 06/2009 - 08/2004
2	Protein Kinase C-alphaIBA 02/2008 - 11/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2007 - 11/2004
2	Protein Kinase CIBA 11/2004 - 12/2003
2	Protein Isoforms (Isoforms)IBA 11/2004 - 12/2003
2	Fibronectins (Fibronectin)IBA 11/2004 - 12/2002
2	Angiotensin IIIBA 08/2004 - 01/2003
2	pimagedine (aminoguanidine)IBA 07/2004 - 12/2002
1	Liraglutide FDA Link 12/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 12/2023
1	Glucagon (Glukagon)FDA Link 01/2023
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2022
1	InflammasomesIBA 01/2022
1	Dietary ProteinsIBA 11/2021
1	ProteomeIBA 07/2021

Therapy/Procedure

18	Therapeutics 12/2023 - 03/2005
3	Glycemic Control 07/2011 - 11/2005
2	Drug Therapy (Chemotherapy) 06/2021 - 04/2020